Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cancer Genetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Aug 2016 Reuters Investment Profile 12 $20.00

CANCER GENETICS INC (CGIX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

27 Aug 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Cancer Genetics Inc (CGIX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Aug 2016 Thomson Reuters Stock Report 12 $25.00

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company that...

17 Aug 2016 GlobalData 64 $300.00

ValuEngine Rating and Forecast Report for CGIX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

CGIX- Q2 revenue and EPS better than expectations, I-O aids backlog growth

Q2 revenue and EPS better than expectations, I-O aids backlog growth

11 Aug 2016 Feltl & Company 8 $81.00

Wright Investors Service Comprehensive Report for Cancer Genetics Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

09 Aug 2016 Wright Reports 60 $75.00

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial Analysis Review Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company that...

16 Jun 2016 GlobalData 60 $300.00

CGIX- Q1 revenue missed, lowering estimates, but immuno-oncology heating up

Q1 revenue missed, lowering estimates, but immuno-oncology heating up

11 May 2016 Feltl & Company 9 $81.00

Thomson Reuters Stock Report - Cancer Genetics Inc (CGIX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00